Incubator Company Profiles
AccelBio provides results for biotechnology applications and pharmaceutical outcomes
with a focus on customized neurobiology discovery research. With AccelBio's expertise
in molecular cell biology and animal work, it leverages premier bioassays in multiple
formats, including high-throughput screens using chemically unique entities for drug
discovery, and exclusive use of superior primary cells through Evergreen Biosciences.
AccelBio's contract services enable the highest quality R&D focused on genetic models
and disease pathways.
Contact
Jason Dictenberg, Ph.D.
CEO
(718) 845-7374
Applied Biological Laboratories Inc. is a biotechnology company committed to research,
development, manufacturing and distribution of scientifically validated natural products.
Azul Bio creates coral microbiome boosters (CMBs) to protect coastal businesses from
the financial impact of coral reef decline. CMBs are the only fast-acting and scalable
method of making wild coral reefs immune to ocean warming.
BioMolecular, Inc. is a leading technology, product and service provider for the life science community. The company has developed a variety of biological research reagents, such as ultra-speed clone vector, ultra-sensitive PCR system, one step Western blot and magic protein sample solution. These reagents are widely used in molecular biological research, drug discovery and clinical diagnosis. The company’s research services include customer gene expression, DNA and RNA purification, gDNA and cDNA library construction, PCR and gene clone, RT-PCR, clinical assay, primer and gene synthesis, DNA sequencing and contracting research project.
Contact
Gang Wu
(917) 362-0788
wug2@yahoo.com
Brekland Incorporated is developing a spray-on insulation to increase specialty crop
growers climate resilience to spring frost.
ChemFinity Technologies, Inc. is developing highly selective adsorbent and membrane
materials that exhibit exceptional performances for molecular separations spanning
across the periodic table. ChemFinity is focused on separations that would help alleviate
environmental injustice issues, with applications in precious metal recovery, water
desalination, and gas separations.
Contact
info@chemfinitytech.com
CMP Scientific Corp. currently develops, manufactures, and sells nanoLC capillary
columns and CE-ESI-MS ion sources. CMP Scientific is founded by experts in the analytical
science field, especially the LC-MS and CE-MS coupling technologies. It seeks to become
an industry leader as an analytical instrumentation company with five core products/services:
nanoLC capillary columns, CE-ESI-MS ion sources, CE instruments, CE consumables, and
CE-ESI-MS CRO service.
Contact
James (Qiangwei) Xia, Ph.D.
CEO & Principal Scientist
(718) 360-7803
Concarlo Holdings, LLC (Concarlo) is a start-up drug development company focused on
innovative therapeutics and diagnostics for unmet needs in oncology.
Contact
LisaMarie Casey
Info@concarlo.com
DrinkSavvy, Inc. is developing colorimetric chemical sensors that detect analytes,
such as drugs, pathogens, bacteria, and explosives, for real-time detection in field
use, without the need for secondary analysis using lab equipment or spectrometry.
The chemical sensors will be embedded in plastic stirrers, straws and cups and provide
a colorimetric signal to the consumer in order to prevent consumption of illicit drugs
and ensuing drug-facilitated sexual assault and crime.
Contact
Brendan Walker
bwalker@drinksavvy.com
Epi One is a start up biotechnology company that aims to develop tests for the clinical diagnosis of diseases.
Contact
(718) 676-0696
info@epi-one.com
Episteme is developing and commercializing a proprietary rapid precision diagnostic
test referred to as PancEpistemeDxTM that can be used to predict patients’ response to first line therapy and is therefore
clinically actionable.
The need for an alternative to one’s own tissue for wound healing and repair has existed as long as reconstructive surgery itself. Fesarius Therapeutics is an early stage company that will develop and manufacture engineered skin and tissue replacement products using patented microsphere hydrogel technology invented by Dr. Jason Spector at the Weill Cornell Medical College Laboratory for Bioregenerative Medicine & Surgery.
Contact
Brett Spector
CEO
brett.spector@fesariustherapeutics.com
HistoWiz, Inc. is a histopathology service company that processes, embeds, cuts, stains
mouse tissue specimens and digitalizes the results for cancer researchers in academia
and pharma. Unlike academic core facilities and CROs, HistoWiz guarantees a 3 day
turn-around time and provides global access to whole-slide digital results, online
collaboration features, low-cost digital data management, a cancer image database,
and mouse cancer pathology expertise. The company's mission is to fight cancer cooperatively
instead of individually by connecting scientists and doctors for online collaboration.
Contact
Ke Cheng
(212) 722-1456
IAVI's Vaccine Design and Development Laboratory (DDL) is a versatile facility designed
to create novel immunogens, develop viral vectors, evaluate potency and advance promising
candidates to clinical evaluation. The DDL has also established common preclinical
standards for the vaccine field. Their goals are to understand the basis of naturally
evoked, broadly neutralizing antibodies against HIV and other Emerging Infectious
Diseases (EID) such as, but not limited to, Lassa fever, Marburg virus, and Covid-19.
Jillion Therapeutics Inc., a cutting-edge Biotechnology start-up, harnesses neuroscience
Nobel Prize-winning lab knowledge, 20+ years’ experience, and scientific rigor to
tackle critical diseases and disorders. Jillion boasts organic chemistry proficiency
(supported by in-house HPLC and LCMS capabilities), coupled with extensive biology
knowledge spanning molecular biology, to cellular levels, to in-vivo studies. With
a robust focus on innovative drug-target identification, Jillion excels in drug screening
through DNA-encoded library (DEL) technology and DEL-focused library construction,
as well as in thorough target validation.
Kinnos Inc. aims to raise the standard of infectious disease decontamination to protect
healthcare workers, patients, and the general public. The company's first product,
Highlight, is a point-of-use additive for existing disinfectants that eliminates human
error and greatly increases visibility, coverage, and end-user compliance.
Contact
team@kinnos.us
Lucerna, Inc. is a RNA-based research tool company that uses a fluorescent aptamer
platform for the purpose of:
- Developing metabolite sensors for therapeutic diagnostics
- Developing fluorescent assays against hard-to-access targets to enable high-throughput drug discovery, and
- Providing plug-and-play RNA imaging systems as research reagents.
Contact
info@lucernatechnologies.com
Lumidyne Technologies specializes in the development and manufacturing of advanced
fluorescent probes that enable a broad range of structural and cell biological imaging
applications.
Contact
(212) 457-4047
Mirimus is a high-tech business with the expertise in RNAi technologies required for
development of superior tools for potent gene silencing, both in cells and animal
models. Its advanced RNAi technologies are critical for the generation of animal models
that can pave the way drugs are developed by pin-pointing potential toxicities and
preventing harmful side-effects of therapeutics in patients. Mirimus is also engaged
in the design, development and pioneering of new CRISPR/Cas9 genome editing technologies
to develop advanced human disease models that are crucial for the preclinical evaluation
of new therapeutics.
Contact
(929) 377-3744
New York Huaqi Bioengineering, LLC develops new products in modification or growth
of liver organ in vitro to meet the shortage of liver organs in clinic.
Contact
Lili Xu
Founder & CEO
(914) 316-0801
lili_xu@optonline.net or
Lili.Xu@downstate.edu
Pierrepont Therapeutics is dedicated to developing targeted treatments for primary mitochondrial diseases. Driven by the unmet needs and advances in research, Pierrepont plans to develop a portfolio of novel clinical stage treatments targeted to specific patient populations with nuclear and mitochondrial DNA mutations.
Contact
info@PierrepontTx.com
Psomagen Corp., previously named Macrogen Corp. in the U.S., has been the corporate
partner of choice on genomic sequencing for many academic and commercial organizations.
The company's superior quality, cost effective business model and customer focused
services allowed it to expand and grow into an international organization. Psomagen's
sequencing experience uniquely positions it to contribute in both the Sanger and the
next generation genomic sequencing.
Relavo, Inc. is a medical device that aims to reduce infection risk associated with
catheters and home therapies. Relavo's initial focus is on changing the way that kidney
failure patients receive treatment by making home dialysis safer and more accessible.
The company's first product, the PeritoneX, is a connection device that disinfects
peritoneal dialysis (PD) tubes to reduce infection risk and enable PD patients to
receive safe, quality care at home.
Contact
info@relavomedical.com
Vasocure is a clinical-stage vascular therapeutics company with the world’s first
peptide to directly treat neointimal disease and atherosclerosis.
Werewool is a biotechnology company developing protein-based, biodegradable textile
fibers with inherent, DNA-programmed color and performance. Driven by the principles
of biomimicry, Werwool fibers are inspired by how nature builds color and function
into materials, to create low impact, compostable, textile fibers with vibrant structural
color and performance properties like strength, stretch and moisture management achieved
through protein engineering. Werewool fibers are engineered to offer the textile industry
performance properties and aesthetics without the high environmental cost of conventional
synthetic fibers and dyes.
Contact
Hello@werewool.bio
Xylyx Bio is revolutionizing the $7B+ cell culture market with its first-in-class
tissue-specific biomaterials, enabling faster, more accurate and actionable results
for scientists working in pharmaceutical development, cell biology research and regenerative
medicine. Rather than isolated components or synthetic materials, the Company’s innovative
product platform provides a natural, physiological cell culture environment in which
to develop, test and deliver treatments and cures to patients more quickly and less
expensively.